PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world’s first and only Self-Apposing® Stent for treating acute myocardial infarction (AMI), today announced the signing of the first distribution partnerships for its stents in Asia.
Help employers find you! Check out all the jobs and post your resume.
